Antibody against N-terminal peptide or C-terminal peptide of GPC3 solubilized in blood

Details for Australian Patent Application No. 2003261941 (hide)

Owner Chugai Seiyaku Kabushiki Kaisha

Inventors Ohizumi, Iwao; Midorikawa, Yutaka; Ito, Yukio; Aburatani, Hiroyuki; Nakano, Kiyotaka; Tokita, Susumu

Agent FB Rice

Pub. Number AU-B-2003261941

PCT Number PCT/JP03/11318

PCT Pub. Number WO2004/022739

Priority PCT/JP02/08999 04.09.02 JP

Filing date 4 September 2003

Wipo publication date 29 March 2004

Acceptance publication date 21 August 2008

International Classifications

C12N 15/06 (2006.01) Mutation or genetic engineering - Animal cells

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/08 (2006.01) Mutation or genetic engineering - Cells resulting from interspecies fusion

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

27 November 2003 Complete Application Filed

  Priority application(s): PCT/JP02/08999 04.09.02 JP

13 May 2004 Application Open to Public Inspection

  Published as AU-B-2003261941

21 August 2008 Application Accepted

  Published as AU-B-2003261941

18 December 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003261942-CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE

2003261940-ACICULAR SILICON CRYSTAL AND PROCESS FOR PRODUCING THE SAME